Alex Goldberg

NASDAQ Active Stock Watch List: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and Atmel Corporation (NASDAQ:ATML) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/10/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and Atmel Corporation (NASDAQ:ATML).

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) a biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases closed up in its previous session (+5.12%) on 1,779,763 shares traded after Sarepta Therapeutics Announced Eteplirsen Demonstrates Stability on Pulmonary Function Tests through 120 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is currently up (+117.16%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Atmel Corporation (NASDAQ:ATML) a company that designs, develops, manufactures, and sells semiconductor integrated circuit products closed down in its previous session (-3.06%) on 8,782,743 shares traded after Atmel Reported Fourth Quarter and Full Year 2013 Financial Results. Atmel Corporation (NASDAQ:ATML) is currently down (-16.95%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Atmel Corporation (NASDAQ:ATML)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com